These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3140254)

  • 1. Effects of some natural and synthetic prostaglandins (PGs) on gastric secretion "in vitro".
    Adami M; Bertaccini G
    Pharmacol Res Commun; 1988 Jul; 20(7):623-4. PubMed ID: 3140254
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspective on the gastric antisecretory effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():68-77. PubMed ID: 3122277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
    McColl KE
    Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
    [No Abstract]   [Full Text] [Related]  

  • 4. GR63799X--a novel prostanoid with selectivity for EP3 receptors.
    Bunce KT; Clayton NM; Coleman RA; Collington EW; Finch H; Humphray JM; Humphrey PP; Reeves JJ; Sheldrick RL; Stables R
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():379-82. PubMed ID: 1825574
    [No Abstract]   [Full Text] [Related]  

  • 5. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Fiske SC
    Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 11-deoxyprostaglandin E1 on secretion of gastric juice].
    Bushueva GI; Manukina TA; Dikovskaia KI
    Fiziol Zh SSSR Im I M Sechenova; 1983 Aug; 69(8):1104-8. PubMed ID: 6628758
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained enhancement of gastric HCO3 secretion in humans by enprostil.
    Guslandi M; Tittobello A
    Therapie; 1991; 46(1):13-5. PubMed ID: 1902327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of misoprostol on gastric acid secretion in vitro. Qualitative differences from natural prostaglandins.
    Bertaccini G; Adami M; Coruzzi G
    Dig Dis Sci; 1988 Oct; 33(10):1265-8. PubMed ID: 3139378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastroduodenal ulcer pathology and prostaglandins].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of prostanoids in the treatment of gastric ulcer.
    Rachmilewitz D
    Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cytoprotection by misoprostol against ethanol-induced gastric mucosal injury in man mediated by somatostatin?
    Godiwala T; Agrawal N; Groot K; Arimura A; Dajani EZ
    Prostaglandins; 1987; 33 Suppl():130-1. PubMed ID: 2892229
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulatory effect of enprostil, an anti-ulcer prostaglandin, on gastric mucus secretion.
    Waterbury LD; Mahoney JM; Peak TM; Cohn RG; Garay GL
    Am J Med; 1986 Aug; 81(2A):30-3. PubMed ID: 3092651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin treatment for peptic ulcer.
    Walt RP
    Scand J Gastroenterol Suppl; 1988; 146():40-9. PubMed ID: 2906468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and peptic ulcer therapy.
    Walt RP
    Scand J Gastroenterol Suppl; 1990; 174():29-36. PubMed ID: 1976271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
    Arakawa T; Kobayashi K
    Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560
    [No Abstract]   [Full Text] [Related]  

  • 17. Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output.
    Sellers LA; Carroll NJ; Allen A
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):91S-95S. PubMed ID: 3080296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDL-646, a new synthetic E1-prostaglandin with local protective effects on the gastric mucosa.
    Spina G; Schiatti P; Selva D; Gallico L; Glässer A
    Prostaglandins; 1984 Aug; 28(2):158-71. PubMed ID: 6542241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of indomethacin-induced gastric ulceration in the rat by 7-oxo-prostaglandin E1 analogs (author's transl)].
    Hoshina K; Kawashima H; Kurozumi S; Hashimoto Y
    Yakugaku Zasshi; 1981 Mar; 101(3):247-53. PubMed ID: 7299636
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral prostaglandin E analogues induce intestinal migrating motor complexes after a meal in dogs. Evidence for a central mechanism.
    Staumont G; Fioramonti J; Frexinos J; Bueno L
    Gastroenterology; 1990 Apr; 98(4):888-93. PubMed ID: 2107114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.